JDVPX
Price
$24.25
Change
+$0.19 (+0.79%)
Updated
Jul 3 closing price
Net Assets
17.98B
VIVIX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

JDVPX vs VIVIX

Header iconJDVPX vs VIVIX Comparison
Open Charts JDVPX vs VIVIXBanner chart's image
JHancock Disciplined Value R2
Price$24.25
Change+$0.19 (+0.79%)
VolumeN/A
Net Assets17.98B
Vanguard Value Index I
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
JDVPX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JDVPX vs. VIVIX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVPX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 189B vs. JDVPX (18B). VIVIX pays higher dividends than JDVPX: VIVIX (2.19) vs JDVPX (0.59). JDVPX was incepted earlier than VIVIX: JDVPX (13 years) vs VIVIX (27 years). JDVPX (1.11) is less costly to investors than VIVIX (0.04). JDVPX is a more actively managed with annual turnover of: 63.00 vs. VIVIX (9.00). JDVPX has a lower initial minimum investment than VIVIX: JDVPX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 11.41 vs. JDVPX (-0.90). VIVIX return over 5 years is better than : 79.11 vs. JDVPX (43.68).
JDVPXVIVIXJDVPX / VIVIX
Total Expense Ratio1.100.042,750%
Annual Report Gross Expense Ratio1.110.042,775%
Fund Existence13 years27 years-
Gain YTD7.3155.609130%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets18B189B10%
Annual Yield % from dividends0.592.1927%
Returns for 1 year-0.9011.41-8%
Returns for 3 years15.9234.4046%
Returns for 5 years43.6879.1155%
Returns for 10 years32.83114.4529%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KB85.701.60
+1.90%
KB Financial Group
BNL16.340.14
+0.86%
Broadstone Net Lease
EYPT9.720.06
+0.62%
EyePoint Pharmaceuticals
ACTU6.59-0.15
-2.23%
Actuate Therapeutics Inc
SNSE9.03-0.24
-2.54%
Sensei Biotherapeutics Inc